EAM
CLVS

Erste Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Erste Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,700
Closed -$212K – 454
2019
Q2 		$212K Hold
15,700
– – 0.01% 362
2019
Q1 		$382K Hold
15,700
– – 0.02% 326
2018
Q4 		$282K Buy
+15,700
New +$321K 0.02% 345

Other funds holding CLVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Erste Asset Management's CLVS Position: Q3 2019 in Review

Erste Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 15,700 shares — an estimated $212K sold.

Erste Asset Management first reported a position in CLVS in Q4 2018 and held it in 3 quarters. The position peaked at $382K in Q1 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

  • Erste Asset Management reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
  • Erste Asset Management sold 15,700 Clovis Oncology, Inc. shares in Q3 2019, an estimated $212K.
  • Erste Asset Management first reported a position in Clovis Oncology, Inc. in Q4 2018 and held it in 3 quarters.
  • Erste Asset Management's Clovis Oncology, Inc. position peaked at $382K in Q1 2019.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on Erste Asset Management's 13F filing for Q3 2019, filed 22 Nov 2024.